Having observed differential expression of type III and II IFNs in the lower respiratory tracts of COVID-19 patients, we evaluated TLR expression in BALs; in particular, deceased patients showed lower expression levels of TLR7 and TLR8 mRNAs. This evidence concerns the gene TLR8 and COVID-19.